daratumumab,talquetamab,teclistamab
genmab,janssen
['talquetamab', 'redirectt-1', 'mmsm', 'multiple myeloma', 'teclistamab']
teclistamab-cqyv in combination with talquetamab showcased early signs of activity with acceptable safety in patients with relapsed/refractory multiple myeloma, according to final results from the phase 1b redirectt-1 study. #asco23 #mmsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.